Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin
about
Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease micePolymorphisms in SELE gene and risk of coal workers' pneumoconiosis in Chinese: a case-control study.Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infectionsInflammatory targets of therapy in sickle cell disease.Impact of hydroxyurea on clinical events in the BABY HUG trial.Minireview: Prognostic factors and the response to hydroxurea treatment in sickle cell disease.Emerging science of hydroxyurea therapy for pediatric sickle cell disease.How we prevent and manage infection in sickle cell disease.Prothrombotic aspects of sickle cell disease.Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia.The effect of hydroxcarbamide therapy on survival of children with sickle cell disease.Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patientsLow-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings
P2860
Q30525565-7AA8C7C4-8EE8-4A61-8B4D-645034EC1838Q34996990-99BDEDF4-06DD-4A68-8519-28632D9BAC47Q36270721-AEFED0F7-BAB9-422D-9808-3AE4A948CAFAQ36385224-058F7AE8-5F8A-4F22-B1EB-F868AF74D052Q36425423-4ACD9FA9-49CF-4B73-BD85-A5FF67650C82Q37107206-4279DFDD-1AF5-430F-8631-E97CB697BDD8Q38164192-2F9D52A3-C31B-427A-80F8-F3F211ED6D2BQ38505129-6C80065F-F706-4FE2-A777-820AC32817A1Q38696998-C6209E89-1897-4B8B-99F1-971C1E0341C1Q49952941-4624B30D-DF8F-436B-A4DF-480BF6DE33DCQ51065755-4E2DDF62-3529-44B6-9111-C6CBA1E4B0B4Q56787000-CDED02F3-397C-4A0E-BE15-4B7EE78E0C50Q58765141-B7DBE86A-7807-4731-BF81-C3CF2E3B3662
P2860
Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hydroxyurea therapy of a murin ...... by down-modulating E-selectin
@ast
Hydroxyurea therapy of a murin ...... by down-modulating E-selectin
@en
type
label
Hydroxyurea therapy of a murin ...... by down-modulating E-selectin
@ast
Hydroxyurea therapy of a murin ...... by down-modulating E-selectin
@en
prefLabel
Hydroxyurea therapy of a murin ...... by down-modulating E-selectin
@ast
Hydroxyurea therapy of a murin ...... by down-modulating E-selectin
@en
P2093
P2860
P1433
P1476
Hydroxyurea therapy of a murin ...... by down-modulating E-selectin
@en
P2093
Derek A Persons
Elaine I Tuomanen
Jason W Rosch
Jeffrey D Lebensburger
Melissa Johnson
Russell E Ware
Tamara I Pestina
Thad Howard
Yunming Hu
P2860
P304
P356
10.1182/BLOOD-2011-08-374447
P407
P577
2011-11-30T00:00:00Z